Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Overview
- Gender
- female
Elisabeth Leiderman is the Chief Financial Officer and Chief Business Officer of Atsena Therapeutics. She previously worked at Decibel Therapeutics as a Chief Financial Officer & Head of Corporate Development. Elisabeth Leiderman attended The Wharton School.
Jobs
Number of Current Jobs
1
Elisabeth Leiderman has 1 current jobs including
Board of Directors and Audit Committee Chair at Bluebird Bio
,
.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
Bluebird Bio
|
Board of Directors and Audit Committee Chair | Oct 1, 2021 | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
